Deutsche Bank’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-100
| Closed | – | – | 4778 |
|
|
2017
Q2 | $0 | Sell |
100
-100
| -50% | – | ﹤0.01% | 4829 |
|
|
2017
Q1 | $0 | Sell |
200
-1,689
| -89% | – | ﹤0.01% | 4778 |
|
|
2016
Q4 | $3K | Sell |
1,889
-60,985
| -97% | -$96.9K | ﹤0.01% | 4362 |
|
|
2016
Q3 | $208K | Sell |
62,874
-61,037
| -49% | -$202K | ﹤0.01% | 3495 |
|
|
2016
Q2 | $532K | Sell |
123,911
-61,932
| -33% | -$266K | ﹤0.01% | 3193 |
|
|
2016
Q1 | $1.04M | Buy |
185,843
+18,899
| +11% | +$106K | ﹤0.01% | 2756 |
|
|
2015
Q4 | $2.87M | Sell |
166,944
-121,338
| -42% | -$2.09M | ﹤0.01% | 2163 |
|
|
2015
Q3 | $6.08M | Buy |
288,282
+1,375
| +0.5% | +$29K | ﹤0.01% | 1655 |
|
|
2015
Q2 | $14.2M | Buy |
286,907
+24,441
| +9% | +$1.21M | 0.01% | 1127 |
|
|
2015
Q1 | $20.5M | Buy |
262,466
+7,592
| +3% | +$594K | 0.01% | 915 |
|
|
2014
Q4 | $15.4M | Buy |
254,874
+42,619
| +20% | +$2.58M | 0.01% | 1146 |
|
|
2014
Q3 | $9.04M | Buy |
212,255
+35,948
| +20% | +$1.53M | 0.01% | 1418 |
|
|
2014
Q2 | $10.9M | Sell |
176,307
-2,752
| -2% | -$170K | 0.01% | 1305 |
|
|
2014
Q1 | $11.6M | Sell |
179,059
-45,372
| -20% | -$2.95M | 0.01% | 1254 |
|
|
2013
Q4 | $12.6M | Sell |
224,431
-43,434
| -16% | -$2.45M | 0.01% | 1191 |
|
|
2013
Q3 | $16.4M | Buy |
267,865
+98,144
| +58% | +$6.02M | 0.01% | 997 |
|
|
2013
Q2 | $9.92M | Buy |
+169,721
| New | +$9.92M | 0.01% | 1250 |
|